Skip to main content
. 2021 Dec 3;186(2):R33–R63. doi: 10.1530/EJE-21-1044

Table 3.

Patients at risk for post-surgical HypoPT and risk mitigation.

Topic Comment References
General Higher rates in
• Thyroid cancer with central lymph node dissection
• Graves’ disease
Risk mitigation
• Awareness
• Preoperative screening of parathyroid function
• Vitamin D status
102, 118, 119
Comorbidities Obesity
Gastrointestinal malabsorption, for example, post gastric bypass, severe IBDRisk mitigation
• Awareness
118
Primary exploration vs repeated surgery Higher risk in
• case of repeated surgeryRisk mitigation
• critical assessment for additional/repeated surgeries
102
Combined thyroid and parathyroid surgery Thyroid and parathyroid disease often co-exist but unnoticed if not specifically evaluated
Risk mitigation
• preoperative evaluation for elective thyroid surgery must include parathyroid function (and vice versa)
102
Total thyroidectomy vs less extensive surgery Risk bilateral surgery > risk unilateral surgery
Risk mitigation
• individualized surgical strategy
120
Bilateral cervical exploration in parathyroid disease Risk bilateral exploration > focused PTX
Risk mitigation
• preoperative localization (ultrasound and nuclear medicine techniques)
• exclusion of FHH (no surgery, see Q1, Primary Hyperparathyroidism)
121

FHH, familial hypocalciuric hypercalcemia; HypoPT, chronic hypoparathyroidism; PHPT, primary hyperparathyroidism; PTX, parathyroidectomy.